Response to neoadjuvant endocrine therapy complements recurrence score

Nat Rev Clin Oncol. 2022 Jun;19(6):360. doi: 10.1038/s41571-022-00641-1.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antineoplastic Agents, Hormonal* / therapeutic use
  • Humans
  • Neoadjuvant Therapy*
  • Neoplasm Recurrence, Local / drug therapy

Substances

  • Antineoplastic Agents, Hormonal